WHY CHOOSE Theranojet®ARA

  • Optimized radiation protection
  • No contamination: the vial support makes it easy to set up and to store for decay
  • Ease of use: quick installation of consumables
  • Lightweight and mobile: reduced weight and easy to handle with 4 swivel wheels
  • Efficiency
  • Security

VIDEO: Theranojet®ARA

DESCRIPTION
CHARACTERISTICS

DESCRIPTION

Theranojet®ARA is an injection pump shield designed for the radiation protected intravenous administration of radiopharmaceutical drugs for RadioPharmaceutical Therapy (RPT) labelled in particular with 177Lu.

Lightweight, mobile and versatile, the Theranojet®ARA pump injection shield allows the user to safely load radiopharmaceuticals using a removable shielded container. It facilitates transport and loading of the vial within the hot lab while reducing the risk of contamination to a minimum.

Designed for optimal radiation protection

Theranojet®ARA guarantees patient complete protection administration. Its secure and configurable infusion pump can detect occlusions or air bubbles. As a result, it guarantees flexibility according to the different protocols used. It prevents any risk of extravasation or the injection or air bubbles.

This lightweight unit with 4 castor wheels, is easy to handle and move around. Its two side handles allow it to be moved effortlessly to carry patient doses to the injection cubicles.

It is made entirely of stainless steel and includes a removable containment tray. Allowing for simple and quick microbiological or radioactive decontamination, when required, without altering the injection shield components.

Theranojet®ARA components

Intravenous bag holders are designed to suspend solute bags (NaCl or amino acid). It also facilitates dose dilution as well as IV tube rinsing.

The support and vial shield enables the bottle to be turned over, ensuring that all the content is fully administered. This system allows direct loading of the therapy vial using a needleless transfer device.

This reduces the risk of contamination, needle stick injuries and allows for a safe location for the dose to decay.

A removable containment tray makes it possible to contain the radiopharmaceutical in the event of a connection problem between the vial and the needleless transfer device.

The tray is non-porous and easily removable, making microbiological and radioactive decontamination easier.

The dual-line pump has an adjustable screen allowing the user to easily visualize and program the infusion settings. Dual channels allow the vial to be rinsed ‘hands-free’ using the second line to ensure the entire radiopharmaceutical dose is administered to the patient with little to no residual.

During infusion, the pump will alert for any occlusions, extravasations or air bubbles, as well as indicate remaining volume to be infused.

The two lines of the pump enable a more gradual injection of the radiopharmaceutical with optimal operator radiation protection while improving the patient comfort and treatment tolerance.

A protection screen and a protection housing protects the user during the injection. The transparency of shielded organic glass makes the tubing and the retention area visible, yet still accessible throughout the operation. The glass and shield are on a hinge, allowing the user to easily access the vial or tubing.

Theranojet ara injection shield for theranostic safely load
radiopharmaceuticals

Theranojet®ARA integrated equipments:

  • Injection pump
  • Patient injection kit
  • Shielded vial shield
  • Shielded installation system of vial shield connection
  • Removal tongs of vial shield connection
  • Shielded cover for decay

This shield can be used for singledose and progressively fractionable injections and can be extended to other uses such as other uses such as alpha therapy, and some diagnostic protocols in nuclear medicine.

Theranojet®ARA paves the way for targeted therapy, which precisely eliminates cancer cells while preserving surrounding healthy tissue. This personalised approach, also known as theranostics, an innovative combination of therapy and diagnosis, maximises the chances of treatment success while reducing undesirable side effects, offering new perspectives in the fight against cancer.

Developed in collaboration with the Parisian Beaujon AP-HP (Assistance Publique – Hôpitaux de Paris) Hospital.

Discover our article about the 1st Lutetium-177 injections with the Theranojet®ARA at the Beaujon AP-HP hospital

CHARACTERISTICS

  • External dimensions (with IV pole):L 712 x D 759 x H 1 760 mm
  • Shielding thickness:
    - Screen made of transparent organic material: eq. 0.5 mm of lead
    - Lower housing made of lead eq. 2mm
  • Components:
    - Dual-pouch IV pole
    - Rotating vial shield support with safety features
    - Lead protective housing
    - Mobile frame
    - Protection screen (Transparent organic glass dim.: L 220 x H 170 mm)
    - 2 swivel wheels
    - 2 swivel wheels with brakes
    - Injection kit support
    - Document holder
  • Materials: 304L stainless steel frame and IV pole
  • Weight: 86 kg
  • Accessories
    - Injection pump
    - Patient injection kit (ref. 00055414)
    - Vial shield (ref. 00050036): Shielding thickness: 16 mm lead glass and 7 mm of lead / Vial volume: 30 mL / Weight with its cap: 3.1 kg
    - Shielded installation system of vial shield connection (ref.: 00051943)
    - Removal tongs of the vial shield connection (ref.: 00055988)
    - Shielded cover for decay (ref. 00054547)
France © 2024 - Lemer Pax